About Augury Medical
Built to close the referral gap.
Augury Medical is a Swiss medtech company developing clinical decision support for primary care physicians — helping GPs identify the right patients for specialist cardiology referral before it's too late.
We are a spin-off of the Bern University of Applied Sciences (BFH-TI), founded on the belief that clinical decisions should start with the patient, not the search bar.
Our mission
Getting cardiology patients the right care at the right time.
We exist to eliminate the referral gap in cardiovascular care — giving primary care physicians the clinical decision support they need to identify at-risk patients before disease progresses to emergency. Every GP who uses Augury should be able to act with the confidence of a specialist.
Our vision
No patient falls through the referral gap.
We believe every patient who qualifies for specialist cardiology care should reach it. By embedding guideline-based intelligence into primary care, we aim to systematically close the gap between identification and treatment — across health systems, regardless of where a patient is seen.
Our story
A gap we couldn't ignore.
The idea behind Augury Medical emerged from a pattern we kept encountering in clinical research: patients who qualified for life-changing cardiac interventions — CRT devices, valve replacements, specialist care — were simply not making it from the GP's office to the right specialist.
Not because the treatments weren't available. Not because clinicians weren't trying. But because navigating fragmented cardiology guidelines under 8-minute appointment pressure, without specialist training, is an unreasonable ask of any GP.
We founded Augury Medical to solve exactly that. By mapping a patient's clinical findings directly to ACC/AHA guideline pathways, we give GPs the expert context they need — instantly, without requiring them to become cardiologists.
The team
Meet the people behind Augury.
A small, focused team combining biomedical engineering, cardiac electrophysiology, and software development — with shared roots in BFH-TI research.
Emily Thompson
Chief Executive Officer
Emily leads product strategy, commercial development, and regulatory affairs at Augury Medical. She co-founded the company as a BFH spin-off after identifying the referral gap problem through clinical research, and has driven its development from concept through early validation and fundraising.
Dr. Marcel Jacomet
Chief Operating Officer
Marcel brings deep expertise in signal processing and cardiac electrophysiology, developed over many years as a senior researcher at BFH-TI. He leads clinical validation, scientific direction, and the ongoing development of Augury's guideline-matching engine.
Bruno Stucki
Chief Technology Officer
Bruno architects and builds the Navicor platform. With a background in electrical engineering, he is responsible for the software systems underpinning the clinical decision support tool — with a strong focus on reliability, security, and medical-grade software practice.
Supported & recognised by
Interested in working with us
or joining the team?
We're always open to conversations with clinicians, partners, and people who share our mission.